CAPTRUST Financial Advisors’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-283
Closed -$1K 4394
2022
Q2
$1K Hold
283
﹤0.01% 4810
2022
Q1
$2K Hold
283
﹤0.01% 4581
2021
Q4
$5K Sell
283
-82
-22% -$1.77K ﹤0.01% 4113
2021
Q3
$7K Buy
365
+349
+2,181% +$13.3K ﹤0.01% 3831
2021
Q2
$1K Buy
16
+6
+60% +$278 ﹤0.01% 4421
2021
Q1
$1K Buy
+10
New +$682 ﹤0.01% 4270

Other funds holding CELL

CAPTRUST Financial Advisors's CELL Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2022, closing a stake of 283 shares — an estimated $1K sold.

CAPTRUST Financial Advisors first reported a position in CELL in Q1 2021 and held it in 6 quarters. The position peaked at $7K in Q3 2021. 113 funds tracked by Wall St. Rank hold CELL as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining PhenomeX Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 283 PhenomeX Inc. Common Stock shares in Q3 2022, an estimated $1K.
  • CAPTRUST Financial Advisors first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 6 quarters.
  • CAPTRUST Financial Advisors's PhenomeX Inc. Common Stock position peaked at $7K in Q3 2021.
  • 113 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.